正常:mPAP=15,PCWP=8,CO=5 → PVR = 1.40 Wood(112 dyn·s/cm⁵) PVR = (15−8)/5 = 7/5 = 1.40 Wood;dyn·s/cm⁵ = 80×1.40 = 112。两项均低于 3 Wood(240 dyn·s/cm⁵)阈值——正常肺循环阻力。{"result":"Pulmonary vascular resistance PVR = (15 − 8) / 5 = 1.40 Wood units (Normal PVR).","metadata":{"input":{"mpap":15,"pcwp":8,"co":5},"result":{"pressureGradient":7,"pvrWood":1.4,"pvrDyn":112,"category":"Normal PVR","method":"PVR = (mPAP − PCWP) / CO; dyn = 80 × Wood","model":"Grossman 1991; Simonneau JACC 2019; Humbert ESC/ERS 2022; StatPearls; LITFL. Not medical advice."}}}
肺动脉高压:mPAP=35,PCWP=10,CO=5 → PVR = 5.00 Wood(升高) PVR = (35−10)/5 = 25/5 = 5.00 Wood;dyn·s/cm⁵ = 80×5.00 = 400。远超 3 Wood 阈值。结合 mPAP 35(>20)和 PCWP 10(≤15),符合毛细血管前肺动脉高压(无其他病因则为第 1 组 PAH)。PVR 是 PAH 靶向治疗(ERA、PDE5i、sGC 激动剂、前列环素类)的目标。{"result":"Pulmonary vascular resistance PVR = (35 − 10) / 5 = 5.00 Wood units (Elevated PVR).","metadata":{"input":{"mpap":35,"pcwp":10,"co":5},"result":{"pressureGradient":25,"pvrWood":5,"pvrDyn":400,"category":"Elevated PVR","method":"PVR = (mPAP − PCWP) / CO; dyn = 80 × Wood","model":"Grossman 1991; Simonneau JACC 2019; Humbert ESC/ERS 2022; StatPearls; LITFL. Not medical advice."}}}